medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 05

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (05)

Prevalence of pregnancy-induced hypertension categories preceding eclampsia

Arriaga-García P, Montes-Martínez V

Language: Spanish
References: 17
Page: 364-372
PDF size: 185.60 Kb.


ABSTRACT

Objective: To determine the prevalence of the different categories of pregnancyinduced hypertension that preceded eclampsia in patients with eclampsia in a Hospital in a southeastern México, from 2013 to 2017.
Materials and Methods: Descriptive, cross-sectional, retrospective study performed by reviewing and analyzing the records of patients with eclampsia attended at the Hospital de Alta Especialidad de Veracruz between 2013 and 2017. The category of pregnancy-induced hypertension prior to the diagnosis of eclampsia was identified and prevalence was estimated using absolute frequencies.
Results: Forty-four patients were studied, with mean age of 20.4 ± 5.1 years, 30 of them primigravida. Preeclampsia with severity criteria was documented in 23 cases, in 8 cases preeclampsia without severity criteria, in 7 cases HELLP syndrome, in 4 cases gestational hypertension. In addition, 2 cases had eclampsia without previous record of hypertension.
Conclusion: Preeclampsia with severity criteria was the most prevalent category of pregnancy-induced hypertension prior to the diagnosis of eclampsia, however there were also cases of preeclampsia without severity criteria, gestational hypertension and even cases without hypertension prior to the convulsive event; so it should not be assumed that eclampsia evolves only from preeclampsia with severity criteria, in order to timely promote prevention, detection and management prior to the onset of seizures or other life-threatening maternal complications, and with this contribute to the reduction of global maternal mortality.


REFERENCES

  1. Say L, Chou D, Gemmill A, Tunçalp Ö, et al. Global causes of maternal death: a WHO systematic analysis. Lancet 2014; 2 (6): E323-E333. https://doi.org/10.1016/S2214- 109X(14)70227-X.

  2. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 (9516): 1066-74. https://doi. org/10.1016/S0140-6736(06)68397-9.

  3. American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. www.spog.org.pe/web/phocadownloadpap/ HypertensioninPregnancy.pdf.

  4. Schenone MH, Miller D, Samson JE, Mari G. Eclampsia characteristics and outcomes: A comparison of two eras. Journal of Pregnancy 2013, Article ID 82604. https://doi. org/10.1155/2013/826045.

  5. Mattar F, Sibai BM. Eclampsia VIII. Risk factors for maternal morbidity. AJOG 2000; 182 (2): P307-312. https://doi. org/10.1016/S0002-9378(00)70216-X.

  6. Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild preeclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res 2015; 41: 831. https://doi.org/10.1111/jog.12697.

  7. Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol 2011; 118: 1102-1107. doi:10.1097/aog.0b013e318231934c.

  8. Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol 2011; 204 (2): 152.e1-9. doi.10.1016/j.ajog.2010.08.049.

  9. Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. Sage Open Medicine 2019. https://doi.org/10.1177/2050312119843700.

  10. Brown MA, Magee LA. Hypertensive disorders of pregnancy. ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. 2018 International Society for the Study of Hypertension in Pregnancy and the American Heart Association. 2018; 72 (1): 24-43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803.

  11. Sibai MD, MD. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Diagnosis. Uptodate Waltham. http://www.uptodate.com.

  12. Liu S, Joseph KS, Liston RM, Bartholomew S. Incidence, risk factors, and associated complications of eclampsia. Obstetrics and Gynecology 2011; 118: 987-94. doi. 10.1097/ AOG.0b013e31823311c1.

  13. Abalos E, Cuesta C, Carroli G, Qureshi Z, et al. Preeclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121 Suppl 1: 14-24. https://doi. org/10.1111/1471-0528.12629.

  14. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494. doi. 10.1056/NEJM199602223340803.

  15. Katz VL, Farmer R, Kuller JA. Preeclampsia into eclampsia: Toward a new paradigm. Am J Obstet Gynecol 2000; 182: 1389-96. https://doi.org/10.1067/mob.2000.106178.

  16. Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead CL. Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol 2011; 118: 995-9. https://doi.org/10.1097/aog.0b013e3182324570.

  17. Knight M. Eclampsia in the United Kingdom 2005. RCGO 2007 BJOG 2007; 114: 1072-78. doi. 10.1111/j.1471- 0528.2007.01423.x.




2020     |     www.medigraphic.com